Author: Rong Xia

Claim CME – Lecture 010525

Posted on | by Rong Xia

CAPA Online CME Lecture Series - 1/5/2025

Please complete the questions before claiming your CME certificate.

Lecture Title: Immunohistochemistry in Breast Pathology, more than Biomarkers

Time: January 5th, 2025

Presenter: Dr. Yuanxin Liang, MD PhD

Please fill out your NAME and TITLE (Such as John Smith, MD) that you would like it to appear on the CME certificate and Email address you want it to be sent.

Although the maximum time selection is 1.5 hours, please only claim your CME credits based on the duration you are in the meeting.

1 / 5

As a result of participating in this lecture activity, I am confident I am able to implement new updates and guidelines to into my practice. Choose ranging from 1 for "Strongly DISAGREE" to 5 for "Strongly AGREE".

2 / 5

Did you perceive any bias toward a "commercial interest" in this activity?

(An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.)

3 / 5

In above question, if your answer is YES, please explain:

4 / 5

What barriers do you face in implementing what you learned at the activity?

5 / 5

List 1-2 changes you plan to make in your practice as a result of this session.

Exit

Posted in CME

Claim CME – Lecture 241215

Posted on | by Rong Xia

CAPA Online CME Lecture Series - 12/15/2024

Please complete the questions before claiming your CME certificate.

Lecture Title: Pattern approach in lung biopsies for interstitial lung diseases

Time: December 15, 2024

Presenter: Dr. Chen Zhang, MD/PhD

Please fill out your NAME and TITLE (Such as John Smith, MD) that you would like it to appear on the CME certificate and Email address you want it to be sent.

Although the maximum time selection is 1.5 hours, please only claim your CME credits based on the duration you are in the meeting.

1 / 5

As a result of participating in this lecture activity, I am confident I am able to implement new updates and guidelines to into my practice. Choose ranging from 1 for "Strongly DISAGREE" to 5 for "Strongly AGREE".

2 / 5

Did you perceive any bias toward a "commercial interest" in this activity?

(An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.)

3 / 5

In above question, if your answer is YES, please explain:

4 / 5

What barriers do you face in implementing what you learned at the activity?

5 / 5

List 1-2 changes you plan to make in your practice as a result of this session.

Exit

Posted in CME

Claim CME – Lecture 241208

Posted on | by Rong Xia

CAPA Online CME Lecture Series - 12/8/2024

Please complete the questions before claiming your CME certificate.

Lecture Title: Mediastinal tumors- diagnostic approaches and pitfalls

Time: December 8, 2024

Presenter: Dr. Liang Lu, MD/PhD

Please fill out your NAME and TITLE (Such as John Smith, MD) that you would like it to appear on the CME certificate and Email address you want it to be sent.

Although the maximum time selection is 1.5 hours, please only claim your CME credits based on the duration you are in the meeting.

1 / 5

As a result of participating in this lecture activity, I am confident I am able to implement new updates and guidelines to into my practice. Choose ranging from 1 for "Strongly DISAGREE" to 5 for "Strongly AGREE".

2 / 5

Did you perceive any bias toward a "commercial interest" in this activity?

(An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.)

3 / 5

In above question, if your answer is YES, please explain:

4 / 5

What barriers do you face in implementing what you learned at the activity?

5 / 5

List 1-2 changes you plan to make in your practice as a result of this session.

Exit

Posted in CME

Claim CME – Lecture 241125

Posted on | by Rong Xia

CAPA Online CME Lecture Series - 11/24/2024

Please complete the questions before claiming your CME certificate.

Lecture Title: Mesothelioma and mesothelial tumors: new update of the guidelines and practical consideration for diagnosis of mesothelioma

Time: November 24, 2024

Presenter: Huihua Li, MD/PhD

Please fill out your NAME and TITLE (Such as John Smith, MD) that you would like it to appear on the CME certificate and Email address you want it to be sent.

Although the maximum time selection is 1.5 hours, please only claim your CME credits based on the duration you are in the meeting.

1 / 5

As a result of participating in this lecture activity, I am confident I am able to implement new updates and guidelines to into my practice. Choose ranging from 1 for "Strongly DISAGREE" to 5 for "Strongly AGREE".

2 / 5

Did you perceive any bias toward a "commercial interest" in this activity?

(An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.)

3 / 5

In above question, if your answer is YES, please explain:

4 / 5

What barriers do you face in implementing what you learned at the activity?

5 / 5

List 1-2 changes you plan to make in your practice as a result of this session.

Exit

Posted in CME

Claim CME – Lecture 241117

Posted on | by Rong Xia

CAPA Online CME Lecture Series - 11/17/2024

Please complete the questions before claiming your CME certificate.

Lecture Title: Practical Challenges in NSCLC Diagnosis: Pearls and Pitfalls in the Era of Targeted and Immunotherapy"

Time: November 17, 2024

Presenter: Haijun (Steve) Zhou, MD/PhD

Please fill out your NAME and TITLE (Such as John Smith, MD) that you would like it to appear on the CME certificate and Email address you want it to be sent.

Although the maximum time selection is 1.5 hours, please only claim your CME credits based on the duration you are in the meeting.

1 / 5

As a result of participating in this lecture activity, I am confident I am able to implement new updates and guidelines to into my practice. Choose ranging from 1 for "Strongly DISAGREE" to 5 for "Strongly AGREE".

2 / 5

Did you perceive any bias toward a "commercial interest" in this activity?

(An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.)

3 / 5

In above question, if your answer is YES, please explain:

4 / 5

What barriers do you face in implementing what you learned at the activity?

5 / 5

List 1-2 changes you plan to make in your practice as a result of this session.

Exit

Posted in CME

Claim CME – Lecture 241103

Posted on | by Rong Xia

Copy – CAPA Online CME Lecture Series – 11/03/2024

Please complete the questions before claiming your CME certificate.

Lecture Title: Circulating Tumor DNA with Some Cases in Lung Cancer

Time: November 3rd, 2024

Presenter: Xiaoling (Lynn) Guo, MD, PhD

Please fill out your NAME and TITLE (Such as John Smith, MD) that you would like it to appear on the CME certificate and Email address you want it to be sent.

Although the maximum time selection is 1.5 hours, please only claim your CME credits based on the duration you are in the meeting.

1 / 5

As a result of participating in this lecture activity, I am confident I am able to implement new updates and guidelines to into my practice. Choose ranging from 1 for “Strongly DISAGREE” to 5 for “Strongly AGREE”.

2 / 5

Did you perceive any bias toward a “commercial interest” in this activity?

(An “ineligible company,” also known as a “commercial interest,” is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.)

3 / 5

In above question, if your answer is YES, please explain:

4 / 5

What barriers do you face in implementing what you learned at the activity?

5 / 5

List 1-2 changes you plan to make in your practice as a result of this session.

Exit

Posted in CME

Claim CME – Lecture 1006

Posted on | by Rong Xia

CAPA Online CME Lecture Series – 10/6/2024

Please complete the questions before claiming your CME certificate.

Lecture Title: Born to be Bad: Molecular Drivers of Inherited Blood Cancer

Time: October 6, 2024

Presenter: Dr. Mark D. Ewalt

Please fill out your NAME and TITLE (Such as John Smith, MD) that you would like it to appear on the CME certificate and Email address you want it to be sent.

Although the maximum time selection is 1.5 hours, please only claim your CME credits based on the duration you are in the meeting.

1 / 5

As a result of participating in this lecture activity, I am confident I am able to implement new updates and guidelines to into my practice. Choose ranging from 1 for “Strongly DISAGREE” to 5 for “Strongly AGREE”.

2 / 5

Did you perceive any bias toward a “commercial interest” in this activity?

(An “ineligible company,” also known as a “commercial interest,” is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.)

3 / 5

In above question, if your answer is YES, please explain:

4 / 5

What barriers do you face in implementing what you learned at the activity?

5 / 5

List 1-2 changes you plan to make in your practice as a result of this session.

Exit

Posted in CME

Claim CME – lecture 0928

Posted on | by Rong Xia

CAPA Online CME Lecture Series (GU Session) - 09/28/2024

Please complete the questions before claiming your CME certificate.

Lecture Title: Pediatric Renal Tumors

Time: September 28, 2024

Presenter: Bonnie Balzer, MD, PhD

Please fill out your NAME and TITLE (Such as John Smith, MD) that you would like it to appear on the CME certificate and Email address you want it to be sent.

Although the maximum time selection is 1.5 hours, please only claim your CME credits based on the duration you are in the meeting.

1 / 5

As a result of participating in this lecture activity, I am confident I am able to implement new updates and guidelines to into my practice. Choose ranging from 1 for "Strongly DISAGREE" to 5 for "Strongly AGREE".

2 / 5

Did you perceive any bias toward a "commercial interest" in this activity?

(An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.)

3 / 5

In above question, if your answer is YES, please explain:

4 / 5

What barriers do you face in implementing what you learned at the activity?

5 / 5

List 1-2 changes you plan to make in your practice as a result of this session.

Exit

Posted in CME